Skip to main content
Premium Trial:

Request an Annual Quote

Chemicon International, Axordia Collaborate to Develop Antibodies From Human Embryonic Stem Cell Lines

NEW YORK, Sept. 30 (GenomeWeb News) - Serologicals announced today that its subsidiary, Chemicon International, has signed an exclusive agreement with Axordia to co-develop new antibody markers from Axordia's proprietary human embryonic stem cell lines.

 

Under terms of the agreement, Axordia will contribute its expertise and materials for antibody generation and characterization, and Chemicon will commercialize the new antibody research tools.

 

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.